蛋白質工程市場規模、佔有率和成長分析（按產品、技術、蛋白質類型、最終用途、蛋白質類型、最終用途和地區）- 產業預測 2025-2032

2023 年蛋白質工程市場規模價值 31 億美元，預計將從 2024 年的 36.4 億美元成長到 2032 年的 131.3 億美元，預測期間（2025-2032 年）的複合年成長率為 17.4%。

由於生物製藥需求的激增以及對基因工程技術的投資的增加，蛋白質工程市場預計將經歷顯著成長。增加醫學研發的資金，特別是針對慢性病的疫苗和生技藥品，將為蛋白質工程提供者創造充足的機會。合成生物學的興起和蛋白質工程技術的進步預計將進​​一步為業務成長開闢新的途徑。此外，全球對個人化醫療和標靶治療的需求預計將推動蛋白質工程產品和服務的銷售。然而，該行業的成長可能面臨圍繞蛋白質工程的智慧財產權糾紛、對蛋白質穩定性的擔憂以及道德問題等挑戰，這些挑戰可能會阻礙長期發展。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

蛋白質工程市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 裝置
• 試劑
• 軟體和服務

蛋白質工程市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 合理蛋白質設計
• 定向進化
• 混合方法
• 從頭蛋白質設計
• 其他

蛋白質工程市場規模（按蛋白質類型和複合年成長率） (2025-2032)

• 市場概況
• 胰島素
• 單株抗體
• 疫苗
• 生長因子
• 集落刺激因子
• 凝血因子
• 干擾素
• 其他

蛋白質工程市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 學術研究所
• 合約研究組織 (CRO)
• 製藥和生物技術公司

蛋白質工程市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（US）
• Merck KGaA（Germany）
• Agilent Technologies, Inc.（US）
• Genscript Biotech Corporation（China）
• Codexis, Inc.（US）
• Danaher Corporation（US）
• Bio-Rad Laboratories, Inc.（US）
• Bruker Corporation（US）
• PerkinElmer, Inc.（US）
• Twist Bioscience Corporation（US）
• New England Biolabs（US）
• Genentech, Inc.（US）
• Promega Corporation（US）
• Sutro Biopharma, Inc.（US）
• Abcam plc.（UK）
• Cyrus Biotechnology, Inc.（US）
• Profacgen（US）
• Creative Biomart（US）
• SeSaM-Biotech GmbH（Germany）

結論和建議

Protein Engineering Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.64 billion in 2024 to USD 13.13 billion by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).

The protein engineering market is poised for significant growth, driven by the surging demand for biopharmaceuticals alongside escalating investments in genetic engineering technologies. Increased funding for medical R&D, particularly for vaccines and biologics targeting chronic diseases, is set to create ample opportunities for protein engineering providers. The rise of synthetic biology and advancements in protein engineering techniques will further open new avenues for business growth. Additionally, the global demand for personalized medicine and targeted therapies is anticipated to boost the sale of protein engineering products and services. However, industry growth may face challenges from intellectual property disputes, protein stability concerns, and ethical issues surrounding protein engineering, which could hinder development in the long term.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Engineering market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Engineering Market Segments Analysis

Global Protein Engineering Market is segmented by Product, Technology, Protein Type, End Use and region. Based on Product, the market is segmented into Instruments, Reagents and Software & Services. Based on Technology, the market is segmented into Rational Protein Design, Directed Evolution, Hybrid Approach, De Novo Protein Design and Others. Based on Protein Type, the market is segmented into Insulin, Monoclonal Antibodies, Vaccines, Growth Factors, Colony Stimulating Factors, Coagulation Factors, Interferon and Others. Based on End Use, the market is segmented into Academic Research Institutes, Contract Research Organizations (CROs) and Pharmaceutical &biotechnology companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Engineering Market

The rising trend of personalized medicine has gained significant traction globally, as individuals seek more targeted and effective treatment options for their health issues. As the understanding of genetic influences on diseases becomes increasingly refined, the demand for personalized therapeutic solutions has surged. This evolution in medical treatment is heavily reliant on protein engineering, which is essential for creating tailored therapies. Consequently, the expanding interest in personalized medicine directly contributes to the growth and expansion opportunities for companies operating within the protein engineering sector, highlighting the interdependence between these two fields in advancing healthcare innovation.

Restraints in the Protein Engineering Market

The Protein Engineering market faces significant challenges primarily due to the complexities involved in achieving desirable stability and functionality in proteins. The intricate nature of proteins makes it difficult to preserve their therapeutic properties, as they are prone to denaturation or aggregation. Such alterations can significantly diminish their effectiveness, hindering the development of innovative protein-based products. Consequently, these challenges may impede the growth potential of the market, as efforts to create stable and functional proteins are met with obstacles that complicate research and development within this sector, ultimately affecting overall market progress.

Market Trends of the Protein Engineering Market

The protein engineering market is witnessing a significant trend towards the adoption of directed evolution techniques, which leverage principles of natural selection in laboratory settings. This innovative approach enables companies to develop novel protein variants that are not purely synthetic, expanding the potential applications across various domains, including therapeutics for chronic diseases. The ability to rapidly generate diverse protein libraries enhances research capabilities, driving collaborations between academia and industry. As the demand for tailored biopharmaceuticals and precision medicine continues to rise, the incorporation of directed evolution is positioning protein engineering as a key player in addressing complex healthcare challenges, shaping a dynamic market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Protein Engineering Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents
• Software & Services

Global Protein Engineering Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Rational Protein Design
• Directed Evolution
• Hybrid Approach
• De Novo Protein Design
• Others

Global Protein Engineering Market Size by Protein Type & CAGR (2025-2032)

• Market Overview
• Insulin
• Monoclonal Antibodies
• Vaccines
• Growth Factors
• Colony Stimulating Factors
• Coagulation Factors
• Interferon
• Others

Global Protein Engineering Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Pharmaceutical & Biotechnology Companies

Global Protein Engineering Market Size & CAGR (2025-2032)

• North America (Product, Technology, Protein Type, End Use)
  • US
  • Canada
• Europe (Product, Technology, Protein Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Protein Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Protein Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Protein Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sutro Biopharma, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyrus Biotechnology, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profacgen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biomart (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeSaM-Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations